Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease

Year 2022, Volume: 5 Issue: 2, 31 - 34, 01.08.2022

Mohammed Alqabasani Nawaf Alkherayf Andrea Lasso Shaun Kilty

Abstract

Background: Aspirin-exacerbated respiratory disease is characterized by asthma, chronic rhinosinusitis with nasalpolyps, and sensitivity to aspirin and other cyclooxygenase-1 inhibitors. The use of medical identification by patients with aspirin-exacerbated respiratory disease can provide essential information to prevent accidental exposure to cyclooxygenase-1 inhibitor medications. There is no available literature on medical identification use in the aspirin-exacerbated respiratory disease patient population.

Methods: A cross-sectional survey study was designed to measure the perception of the need for a medical identification and its use by the patients diagnosed with aspirin-exacerbated respiratory disease at The Ottawa Hospital.

Results: Six hundred eighty patients were identified in our registry with a documented sensitivity to nonsteroidal anti-inflammatory drugs or aspirin; 12 additional patients were identified during a clinical visit. A total of 68 patients withaspirin-exacerbated respiratory disease met the inclusion criteria. Twenty-one patients were successfully enrolled. The majority (81%, n = 17) of the patients were not using any medical identification. The most common reason reported by patients for not using the medical identification was a lack of knowledge and awareness regarding its significance.

Conclusion: In this survey of patients with aspirin-exacerbated respiratory disease, patients were found to have little knowledge regarding the benefits of medical identification use. Subsequently, medical identification use was very limited, supporting a clear need for further patient education and awareness.

Keywords

AERD , aspirin sensitivity , samter’s

References

• Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89(5):474-478.
• Szczeklik A, Nizankowska E, Sanak M, Swierczynska M. Aspirin-induced rhinitis and asthma. Curr Opin Allergy Clin Immunol. 2001;1(1):27-33.
• Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. Allergy. 2019;74(1):28-39.
• Savino PB, Sporer KA, Barger JA, et al. Chest pain of suspected cardiac origin: current evidence-based recommendations for prehospital care. West J Emerg Med. 2015;16(7):983-995.
• Zideman DA, Singletary EM, De Buck EDJ, et al. Resuscitation-Part 9: First aid: 2015 International Consensus on First Aid Science with treatment recommendations. Resuscitation. 2015;95:e225-e261.
• Quan D, LoVecchio F, Clark B, Gallagher JV, 3rd. Prehospital use of aspirin rarely is associated with adverse events. Prehosp Disaster Med. 2004;19(4):362-365.
• Morton L, Murad S, Omar RZ, Taylor K. Importance of emergency identification schemes. Emerg Med J. 2002;19(6):584-586. [CrossRef]
• Kiladejo A, Palumbo M, Laidlaw TM. Accidental ingestion of aspirin and nonsteroidal anti-inflammatory drugs is common in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2019;7(5): 1656-1658.e2.
• Buhl T, Meynberg HC, Kaune KM, Hünecke P, Schön MP, Fuchs T. Long-term follow-up of patients with hypersensitivity to nonsteroidal anti-inflammatory drugs reveals shortcomings in compliance and care. J Allergy Clin Immunol. 2011;127(1):284-285.
• Aun MV, Blanca M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420.
• Chadwick S, Shah M. Tattoos: ancient body art may assist in medical emergencies. Eur J Pediatr. 2013;172(7):995.
• Rahman S, Walker D, Sultan P. Medical identification or alert jewellery: an opportunity to save lives or an unreliable hindrance? Anaesthesia. 2017;72(9): 1139-1145.
• Barot PA, Malhotra SD, Rana DA, Patel VJ, Patel KP. Drug utilization in emergency medicine department at a tertiary care teaching hospital: a prospective study. J Basic Clin Pharm. 2013;4(4):78-81.
• MedicAlert Foundation; 2022. Available at: https://www.medicalert.org/. Accessed February 10, 2022.
• Stallwood L. Medical alert identification: a “scarlet letter” or tool for diabetes management. J Pediatr Health Care. 2005;19(6):400-404.
• Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect. 2001;7(12):657-660.
• Gorlin JB, Hooke MC, Leonard N. Use of emergency medical identification in the paediatric haemophilia population: a national study. Haemophilia. 2011;17(2):215-222.
• Vachharajani T. Medical alert bracelet: an effective way to preserve veins for future dialysis vascular access in patients with chronic kidney disease.­ Medscape J Med. 2009;11(1):1.
• Alzheimer’s Society of Canada. Medicalert, safely home. Alzheimer's Society of Canada; 2022. Available at: https://alzheimer.ca/en/help-support/programs-services/medicalert-safely-home. Accessed Feb 14, 2022.
• Le T-TA, Foreman C, Smith WB. The use of medical alert jewelry to communicate allergy information. J Allergy Clin Immunol Pract. 2019;7(3):1083-1085.
• Farhy E, Diamantidis CJ, Doerfler RM, Fink WJ, Zhan M, Fink JC. Use of a medical-alert accessory in CKD: a pilot study. Clin J Am Soc Nephrol. 2019;14(7):994-1001.
• Grüninger UJ. Patient education: an example of one-to-one communication. J Hum Hypertens. 1995;9(1):15-25.
• Kennedy JM, Vargus B. Challenges in survey research and their implications for philanthropic studies research. Nonprofit Volunt Sect Q. 2001;30(3):483-494.